DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages

Hyperbaric oxygen therapy

Author: Juhee Roh, Medical Student, University of Auckland, Auckland, New Zealand. DermNet NZ Editor in Chief: Adjunct A/Prof Amanda Oakley, Hamilton, New Zealand. Copy edited by Gus Mitchell. July 2019.

What is hyperbaric oxygen therapy?

Hyperbaric oxygen therapy is a treatment in which a patient breathes pure oxygen while subject to increased levels of atmospheric pressure. It is a primary or adjunctive treatment for carbon monoxide poisoning, severe decompression sickness, arterial gas embolism, and chronic wounds [1].

There are over 500 hyperbaric facilities in the United States, but hyperbaric oxygen is less widely used elsewhere [2].

What are the indications for hyperbaric oxygen therapy?

Hyperbaric oxygen therapy is primarily used to treat patients with:

  • Carbon monoxide poisoning
  • Decompression sickness
  • Arterial gas embolism
  • Chronic wounds [1,3].

Carbon monoxide poisoning

Carbon monoxide [CO] poisoning can occur on inhaling combustion fumes, especially in an enclosed space. Occupations at risk include firefighters, miners, and people exposed to a charcoal or gas fire indoors with inadequate ventilation [4,5]. Carbon monoxide poisoning is also induced by cyanide.

Decompression sickness

Decompression sickness occurs most commonly in scuba or deep-sea divers breathing compressed air. It also occurs at high-altitude or during deep pressurised air travel [6].

Arterial gas embolism

Arterial gas embolism also occurs during diving and after unexpected rapid depressurisation of an aeroplane or spacecraft above 5500 metres altitude [7]. Air can also be directly introduced into the circulation during central venous catheter placement, cardiac, neurological, and otolaryngological surgery [1]. People who have a patent foramen ovale are at an increased risk of arterial gas embolism [1].

Poor wound healing

Poor wound healing can be due to local, regional, systemic, or miscellaneous causes. It can occur in those with tissue ischaemia, active bacterial skin infection, arterial and venous insufficiency, diabetes mellitus, exposure to radiation, smoking, and the use of vasoconstrictive drugs [8].

A chronic ulcer before and after hyperbaric oxygen therapy

Other uses for hyperbaric oxygen therapy

Hyperbaric oxygen is sometimes used to treat a diverse range of medical conditions, including:

  • Acute crush injury and other forms of traumatic ischaemia
  • Radiation necrosis of soft tissue and bone
  • Necrotising soft tissue infection
  • Refractory osteomyelitis
  • Compromised skin graft or flap
  • Severe anaemia
  • Actinomycotic brain abscess [2,9–11].

Hyperbaric oxygen can improve healing after acute traumatic crush injury and compartment syndrome resulting in fewer skin flaps, grafts, and amputations [12,13]. In contrast, there is insufficient evidence to support the use of hyperbaric oxygen for burns [14,15].

The use of hyperbaric oxygen for soft tissue radionecrosis and osteoradionecrosis is controversial [16–20]. Current guidelines for prevention and treatment recommend 20 to 30 preoperative 90-minute sessions of hyperbaric oxygen at 2.4 atm (atmospheres) followed by 10 postoperative sessions [17].

Hyperbaric oxygen is used as an adjunctive treatment for aggressive soft tissue infections such as clostridial myonecrosis (gas gangrene), necrotising fasciitis, and Fournier gangrene [21–27]. It should be commenced early, with two to three daily 90-minute sessions at 3 atm [17]. It is unclear whether hyperbaric oxygen therapy is useful for cutaneous soft-tissue and rhinocerebral mucormycosis (zygomycosis), actinomycotic brain abscesses, or refractory osteomyelitis [1].

Hyperbaric oxygen is used as an adjunctive therapy to treat non-healing ulcers, skin grafts, and to promote wound healing, although there is limited evidence to support its routine use [28–30]. Patients who require skin grafting or reconstructive flaps in areas with compromised blood flow, previous radiation therapy, or in sites of previous graft failure may benefit from prophylactic treatment.

Many other diseases have been treated with hyperbaric oxygen without evidence to support the treatment. Further research is required to confirm any benefits and justify its substantial costs and potential risks [1,31].

How does hyperbaric oxygen therapy work?

Hyperbaric oxygen therapy is usually performed as an outpatient procedure and does not require hospitalisation. Details depend on the hyperbaric oxygen facility and the indication for treatment.

Hyperbaric oxygen therapy involves breathing 100% pure oxygen in either a monoplace chamber (treats one patient at a time) or a multiplace chamber (treats two or more patients at once).

Pressures of 2.5 to 3.0 times normal atmospheric air pressure are generally recommended for both types of chamber [32].

  • The treatment typically lasts 120 minutes with a range of 45 to 300 minutes [1,31].
  • Acute cases may require only one or two sessions.
  • Patients with residual deficits from decompression sickness should receive repeated treatments, which may take several days to achieve a therapeutic effect [1].
  • Chronic ulcers may require up to 30 or more treatments [1,31].

Monoplace chamber

The monoplace chamber is designed for one person and is appropriate for treatment of a chronic medical condition in a stable patient [9]. The patient lies on a table that slides into a clear plastic tube, similar to an MRI machine [3].

Multiplace chamber

The multiplace chamber is designed for two or more people and allows close monitoring of a critically ill patient [1,31]. The large chamber resembles a hospital room and the patient may sit or lie down. Oxygen is received through a mask or through a transparent, lightweight hood [3,31].

What is the mechanism of action of hyperbaric oxygen?

The mechanism of action depends on the condition being treated.

Carbon monoxide poisoning

Carbon monoxide [CO] has 200–250 times greater affinity to haemoglobin than oxygen, reducing the oxygen-carrying capacity of the blood [1]. The normal half-life of carboxyhaemoglobin is four to six hours; hyperbaric oxygen therapy reduces its half-life to 15–30 minutes [33,34].

Decompression sickness

According to Boyle’s Law (the relationship between gas concentration, volume and pressure), the volume of nitrogen bubbles decreases by approximately two-thirds at 3.0 atm. Hyperbaric oxygen therapy thus reduces the size of nitrogen gas bubbles and replaces inert nitrogen with oxygen [9]. The residual nitrogen is metabolised in the tissues.

Chronic wounds

Hyperbaric oxygen therapy achieves its therapeutic effect by increasing the oxygen delivered to injured tissue.

The concentration of oxygen dissolved in plasma at sea level is 0.3 mL/dL. Applying the principles of Henry’s Law, hyperbaric oxygen administered at 3.0 atm results in a dissolved plasma oxygen concentration of 6 mL/dL [1]. The delivery of oxygen in high concentration to injured tissues can restore tissue function, stimulate healing, and resist infection [31].

In vitro studies have demonstrated that reactive oxygen and nitrogen species are the key mediators in acute and chronic injury, ischaemia, and inflammation [35–37].

An excessive concentration of oxygen (local hyperoxia) induces the following effects:

  • Stimulates constriction of the blood vessels (vasoconstriction)
  • Reduces vasogenic oedema [35]
  • Reduces leukocyte influx as a result of reperfusion injury (blood supply returning to the tissue after a lack of oxygen) [36]
  • Increases fibroblast proliferation
  • Increases angiogenesis [12,17]
  • Increases neutrophil bactericidal activity, limiting clostridial exotoxin and spore production, killing anaerobes such as Clostridium perfringens, and inhibiting the growth of other bacterial pathogens [17,38–40].

What are the contraindications with hyperbaric oxygen therapy?

Untreated pneumothorax is an absolute contraindication to hyperbaric oxygen therapy [1]. Relative contraindications include:

  • Obstructive lung disease
  • Asymptomatic pulmonary blebs or bullae
  • Upper respiratory or sinus infection
  • Recent ear or thoracic surgery
  • Ear trauma
  • Uncontrolled fever [1,4].

What are the side effects and risks of hyperbaric oxygen therapy?

Side effects of hyperbaric oxygen therapy may include:

  • A temporary feeling of fullness in the ears relieved by yawning or swallowing [31]
  • Transient lightheadedness or hunger [3]
  • Claustrophobia, fatigue and headaches [1,4].

Complications of hyperbaric oxygen therapy

The most common complication of hyperbaric oxygen therapy is middle ear barotrauma (pressure-related trauma) with an incidence of approximately 2%; this may infrequently result in middle ear effusions and tympanic membrane rupture [41]. Pressure-related middle ear injury can be prevented through autoinflation techniques and placement of tympanostomy tubes [41].

The second most common complication is sinus barotrauma, which is usually seen in patients with upper respiratory tract infections or allergic rhinitis [1]. The risk can be minimised by nasal decongestants, steroids, or histamines prior to hyperbaric oxygen [41].

Rare complications may include:

  • Pulmonary barotrauma and toxicity [1,9]
  • Decompression sickness in patients inhaling nitrogen-containing compressed air [1,4]
  • Toxicity to the lens and temporary myopia (nearsightedness) [41]
  • Seizures [1,4,17,42]
  • Interactions with drugs [1].


Pure oxygen is a serious fire risk.

Potential fire hazards such as lighters, battery-powered devices, and petroleum-based hair and skincare products should be removed prior to the procedure [31].

See smartphone apps to check your skin.
[Sponsored content]


Related information



  1. Crawford C, Manaker S. Hyperbaric oxygen therapy. Available at: [accessed 28 September 2018).
  2. Undersea & Hyperbaric Medical Society. Available at: [accessed 28 September 2018).
  3. Johns Hopkins Medicine. Hyperbaric Oxygen Therapy for Wound Healing. Available at:,44 [accessed 28 September 2018).
  4. Johns Hopkins Medicine. Complications of Hyperbaric Oxygen Treatment. Available at:,148 [accessed 28 September 2018).
  5. Mayo Foundation for Medical Education and Research. Carbon monoxide poisoning. Available at: [accessed 28 September 2018).
  6. Harvard Health Publishing. Decompression Sickness. Available at: [accessed 28 September 2018].
  7. Walker JR, Murphy-Lavoie H. Diving, Gas Embolism. StatPearls 21 February 2018. Available at: [accessed 28 September 2018).
  8. DermNet NZ. Abnormal wound healing.
  9. Leach RM, Rees PJ, Wilmshurst P. Hyperbaric oxygen therapy. BMJ 1998; 317: 1140–3. PubMed Central
  10. Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM: An International Journal of Medicine 2004; 97: 385–95. Available at: [accessed 28 September 2018).
  11. Mathieu D, Marroni A, Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving and Hyperbaric Medicine 2017; 47: 24–32. Available at: [accessed 28 September 2018).
  12. Wattel F, Mathieu D, Nevière R, Bocquillon N. Acute peripheral ischaemia and compartment syndromes: a role for hyperbaric oxygenation. Anaesthesia 1998; 53: 63–5. DOI: 10.1111/j.1365-2044.1998.tb15161.x. PubMed
  13. Bouachour G, Cronier P, Gouello JP, et al. Hyperbaric oxygen therapy in the management of crush injuries: a randomized double-blind placebo-controlled clinical trial. J Trauma 1996; 41: 333–9. PubMed
  14. Brannen AL, Still J, Haynes M, et al. A randomized prospective trial of hyperbaric oxygen in a referral burn center population. Am Surg 1997; 63: 205–8. PubMed
  15. Villanueva E, Bennett MH, Wasiak J, Lehm JP. Hyperbaric oxygen therapy for thermal burns. Cochrane Database Syst Rev 2004; 3: CD004727. PubMed
  16. Marx RE, Ehler WJ, Tayapongsak P, Pierce LW. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg 1990; 160: 519–24. PubMed
  17. Roth RN, Weiss LD. Hyperbaric oxygen and wound healing. Clin Dermatol 1994; 12: 141. PubMed Central
  18. Mustoe TA, Porras-Reyes BH. Modulation of wound healing response in chronic irradiated tissues. Clin Plast Surg 1993; 20: 465–72. PubMed 
  19. Spiegelberg L, Djasim UM, van Neck HW, et al. Hyperbaric oxygen therapy in the management of radiation-induced injury in the head and neck region: a review of the literature. J Oral Maxillofac Surg 2010; 68: 1732–9. PubMed
  20. Bennett MH, Feldmeier J, Hampson NB, et al. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev 2016; 4: CD005005. PubMed
  21. Wilkinson D, Doolette D. Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection. Arch Surg 2004; 139: 1339. PubMed
  22. Pizzorno R, Bonini F, Donelli A, et al. Hyperbaric oxygen therapy in the treatment of Fournier's disease in 11 male patients. J Urol 1997; 158: 837. PubMed
  23. Hollabaugh RS Jr, Dmochowski RR, Hickerson WL, Cox CE. Fournier's gangrene: therapeutic impact of hyperbaric oxygen. Plast Reconstr Surg 1998; 101: 94. PubMed
  24. Green RJ, Dafoe DC, Raffin TA. Necrotizing fasciitis. Chest 1996; 110: 219–29. PubMed
  25. Brown DR, Davis NL, Lepawsky M, et al. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg 1994; 167: 485. PubMed
  26. Riseman JA, Zamboni WA, Curtis A, et al. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery 1990; 108: 847. PubMed
  27. Demello FJ, Haglin JJ, Hitchcock CR. Comparative study of experimental Clostridium perfringens infection in dogs treated with antibiotics, surgery, and hyperbaric oxygen. Surgery 1973; 73: 936. PubMed
  28. Wang C, Schwaitzberg S, Berliner E, et al. Hyperbaric oxygen for treating wounds: a systematic review of the literature. Arch Surg 2003; 138: 272. PubMed
  29. Kranke P, Bennett MH, Martyn-St James M, et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2012; CD004123. doi: 10.1002/14651858.CD004123.pub3. PubMed
  30. Margolis DJ, Gupta J, Hoffstad O, et al. Lack of effectiveness of hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of amputation: a cohort study. Diabetes Care 2013; 36: 196–6. PubMed
  31. Mayo Foundation for Medical Education and Research. Hyperbaric oxygen therapy. Available at: [accessed 28 September 2018).
  32. Moon RE, Sheffield PJ. Guidelines for treatment of decompression illness. Aviat Space Environ Med 1997; 68: 234–43. PubMed
  33. Pace N, Strajman E, Walker El. Acceleration of carbon monoxide elimination in man by high pressure oxygen. Science 1950; 111: 652–4. PubMed
  34. Ernst A, Zibrak JD. Carbon monoxide poisoning. N Engl J Med 1998; 339: 1603–8. PubMed
  35. Nylander G, Lewis D, Nordström H, Larsson J. Reduction of postischemic edema with hyperbaric oxygen. Plast Reconstr Surg 1985; 76: 596–603. PubMed
  36. Zamboni WA, Wong HP, Stephenson LL. Effect of hyperbaric oxygen on neutrophil concentration and pulmonary sequestration in reperfusion injury. Arch Surg 1996; 131: 756–60. PubMed
  37. Luongo C, Imperatore F, Cuzzocrea S, et al. Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit Care Med 1998; 26: 1972–6. PubMed
  38. Kaye D. Effect of hyperbaric oxygen on Clostridia in vitro and in vivo. Proc Soc Exp Biol Med 1967; 124: 360–6. PubMed
  39. Hill GB, Osterhout S. Experimental effects of hyperbaric oxygen on selected clostridial species. I. In-vitro studies. J Infect Dis 1972; 125: 17–25. PubMed
  40. Mader JT, Brown GL, Guckian JC, et al. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis 1980; 142: 915–22. PubMed
  41. Camporesi EM, Bosco G. Mechanisms of action of hyperbaric oxygen therapy. Undersea Hyperb Med 2014; 41: 247–52. PubMed
  42. Hadanny A, Meir O, Bechor Y, et al. Seizures during hyperbaric oxygen therapy: retrospective analysis of 62,614 treatment sessions. Undersea Hyperb Med 2016; 43: 21. PubMed

On DermNet NZ

Other websites

Books about skin diseases